¹Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, Maryland, USA

²Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases/NIH, Bethesda, Maryland, USA

³Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA

⁴National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland, USA

Correspondence to: T Ried, Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH, 50 South Drive, Room 1306, Bethesda, Maryland, MD 20892-8010, USA; E-mail: riedt@mail.nih.gov

^aCurrent address: Avalon Pharmaceuticals, 19 Firstfield Road, Gaithersburg, Maryland, MD 20878, USA

BRCA1 mutation carriers have an increased susceptibility to breast and ovarian cancer. Excision of exon 11 of Brca1 in the mouse, using a conditional knockout (Cre-loxP) approach, results in mammary tumor formation after long latency. To characterize the genomic instability observed in these tumors, to establish a comparative map of chromosomal imbalances and to contribute to the validation of this mouse model of breast cancer, we have characterized chromosomal imbalances and aberrations using comparative genomic hybridization (CGH), and spectral karyotyping (SKY). We found that all tumors exhibit chromosome instability as evidenced by structural chromosomal aberrations and aneuploidy, yet they display a pattern of chromosomal gain and loss that is similar to the pattern in human breast carcinomas. Of note, nine of 15 tumors exhibited a gain of distal chromosome 11, a region that is orthologous to human chromosome 17q11-qter, the mapping position of Erbb2. However, our analysis suggests that genes distal to Erbb2 are the main targets of amplification. Four of the tumors also exhibited a copy number loss of proximal chromosome 11 (11A-B), a region orthologous to human 17p. In eight of the tumors we observed whole or partial gain of chromosome 15 centering on 15D2-D3 (orthologous to human chromosome 8q24), the map location of the c-Myc gene, and six of the tumors exhibited copy number loss of whole or partial chromosome 14, including 14D3, the map location of Rb1. We conclude that despite the tremendous shuffling of chromosomes during the course of mammalian evolution, the pattern of genomic imbalances is conserved between BRCA1-associated mammary gland tumors in mice and humans. Western blot analysis showed that while p53 is absent or mutated in some tumors, at least two tumors revealed wild-type protein, suggesting that other genetic events may lead to tumorigenesis. Similar to BRCA1-deficient mouse embryonic fibroblasts, the tumor cells contained supernumerary functional centrosomes with intact centrioles whose presence results in multipolar mitoses and aneuploidy.

Oncogene (2002) 21, 5097-5107. doi:10.1038/sj.onc.1205636

Brca1; mouse models; SKY; genomic imbalances; centrosome